NCT03614000

Brief Summary

A significant group of children with functional constipation (FC) continues to have symptoms despite recommended standard therapy. Underlying psychiatric problems could explain therapy resistance. However, a work-up for psychiatric problems is only recommended after unsuccessful 6 months standard therapy. Earlier detection and check-up could lead to faster start-up of a more adequate therapy. Therefore, we investigate the prevalence of emotional, behavioural and social problems in the FC-population at the first contact with a paediatric gastroenterologist in a tertiary care hospital.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 12, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 7, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

August 3, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2021

Completed
Last Updated

May 22, 2020

Status Verified

May 1, 2020

Enrollment Period

3.6 years

First QC Date

July 7, 2018

Last Update Submit

May 20, 2020

Conditions

Keywords

Childhood Constipation

Outcome Measures

Primary Outcomes (2)

  • The prevalence of internalizing and externalizing behavioural problems as assessed by the Aseba questionnaires

    The set of Aseba Questionnaires is a validated diagnostic tool that can be filled in by the parents, teachers or children to evaluate various behavioral and emotional problems. It assesses internalizing (i.e., anxious, depressive and over-controlled) and externalizing (i.e., aggressive, hyperactive, noncompliant and under-controlled) behaviors. It is the most widely used instrument for assessing child behavioral and emotional symptoms and can be converted into standardized scores (e.g., T scores Mean = 50, SD = 10) with higher scores indicating more emotional problems.

    1 year

  • The prevalence of behavioural and social responsiveness problems as assessed by the Social Responsiveness Scale-2.

    Social Responsiveness Scale (SRS-2) is a validated 65-item scale for the screening of ASD that requires parents to rate the child's behaviors in the previous 6 months. The questionnaire assesses interpersonal behavior, communication and repetitive/stereotypic behavior characteristics of ASD.

    1 year

Other Outcomes (1)

  • The number of positive screens for parental stress as assessed by the OBVL questionnaires.

    1 year

Study Arms (1)

positive screenings

EXPERIMENTAL
Other: Screening Questionnaires

Interventions

Measurement tools: * Social Responsiveness Scale (SRS-2) is a validated 65-item scale for the screening of ASD that requires parents to rate the child's behaviors in the previous 6 months. The questionnaire assesses interpersonal behavior, communication and repetitive/stereotypic behavior characteristics of ASD. * The Aseba Questionnaires are validated diagnostic tools that can be filled in by the parents, teachers or children to evaluate various behavioral and emotional problems. The CBCL assesses internalizing (i.e., anxious, depressive and over-controlled) and externalizing (i.e., aggressive, hyperactive, noncompliant and under-controlled) behaviors. * The VG\&O The VG\&O is a questionnaire developed in Dutch that gives a subscale of parental stress (OBVL), family functioning (VGFO), education habits (VSOG) and life events (VMG). The OBVL will be used

positive screenings

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children presenting for the first time at the department of Pediatrics of the Universitair Kinderziekenhuis Brussel with complaints of constipation will be included regardless of previously diagnosed behavioral and developmental health problems and regardless of any previous treatment for functional defecation disorders.
  • Developmental age 4-18 years
  • Children and parents who express themselves fluently in Dutch or French
  • Children who meet the Rome IV criteria for the diagnosis of functional constipation in children
  • Children with developmental age of at least 4 years
  • At least two of the following present at least once per week for at least one month.
  • Two or fewer defecations in the toilet per week
  • At least one episode of fecal incontinence per week
  • History of retentive posturing or excessive volitional stool retention
  • History of painful or hard bowel movements
  • Presence of a large fecal mass in the rectum
  • History of large-diameter stools that may obstruct the toilet
  • The symptoms cannot be fully explained by another medical condition.

You may not qualify if:

  • Children with an underlying disease that could have contributed to the development of constipation: Celiac disease, Hypothyroidism, hypercalcemia, hypokalemia, Diabetes mellitus, Dietary protein allergy, Drugs, toxics, Vitamin D intoxication, Botulism, Cystic fibrosis, Hirschsprung Disease, Anal achalasia, Colonic inertia, Anatomic malformations, Pelvic mass (sacral teratoma), Spinal cord anomalies, trauma, tethered cord, Abnormal abdominal musculature (prune belly, gastroschisis, Downsyndrome), Pseudoobstruction (visceral neuropathies, myopathies, mesenchymopathies), Multiple endocrine neoplasia type 2B
  • Children with functional non-retentive fecal incontinence (FNRFI).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Kinderziekenhuis Brussel

Jette, Brussels Capital, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Mental DisordersDevelopmental DisabilitiesAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersChild Development Disorders, Pervasive

Central Study Contacts

Secretariaat Kinderpsychiatrie

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASO Kinder- en Jeugdpsychiatrie

Study Record Dates

First Submitted

July 7, 2018

First Posted

August 3, 2018

Study Start

January 12, 2018

Primary Completion

August 12, 2021

Study Completion

October 12, 2021

Last Updated

May 22, 2020

Record last verified: 2020-05

Locations